JNJ-77242113 is an experimental peptide and orally administered interleukin-23 receptor antagonist that was developed to treat psoriasis.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.